VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
LYEL
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
LYELLyell Immunopharma, Inc.
$15.91$371M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksLYELQuarterly Financials

Lyell Immunopharma, Inc. (LYEL) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Lyell Immunopharma, Inc. (LYEL) quarterly income statement — complete revenue, gross profit & net income history

LYEL Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue2K6K15K8K7K11K34K13K3K13K25K27K65K48.39M3K35.74M553K2.82M2.75M2.63M
Revenue Growth %-71.43%-45.45%-55.88%-38.46%133.33%-15.38%36%-51.85%-95.38%-99.97%733.33%-99.92%-88.25%1614.6%-99.89%1260.01%-77.38%22.06%--
Cost of Goods Sold2.33M000000005.06M5.1M4.54M5.03M4.59M4.17M3.73M3.97M3.99M00
COGS % of Revenue116600%--------38900%20416%16811.11%7733.85%9.49%139066.63%10.44%718.44%141.39%--
Gross Profit-2.33M6K15K8K7K11K34K13K3K-5.04M-5.08M-4.51M-4.96M43.79M-4.17M32.01M-3.42M-1.17M2.75M2.63M
Gross Margin %-116500%100%100%100%100%100%100%100%100%-38800%-20316%-16711.11%-7633.85%90.51%-138966.63%89.56%-618.44%-41.39%100%100%
Gross Profit Growth %-33385.71%-45.45%-55.88%-38.46%133.33%100.22%100.67%100.29%100.06%-111.52%-21.83%-114.1%-45.09%3849.49%-251.32%1118.07%-518.44%-150.52%--
Operating Expenses43.83M61.32M37.27M47.15M57.37M201.16M50.54M51.54M55.58M54.79M55.5M61.36M59.49M59.79M62.52M69.04M67.28M47.17M51.92M65.33M
OpEx % of Revenue2191350%1021966.67%248453.33%589350%819628.57%1828709.09%148644.12%396469.23%1852600%421430.77%221992%227248.15%91523.08%123.56%2083966.67%193.18%12166%1671.44%1884.43%2486.11%
Selling, General & Admin9.55M10.62M10.69M9.79M14.05M14.52M11.77M12.26M13.49M13.17M15.51M19.03M19.28M26.35M26.08M30.45M34.42M31.87M21.24M19.11M
SG&A % of Revenue477750%176933.33%71246.67%122325%200657.14%132018.18%34614.71%94276.92%449800%101284.62%62028%70481.48%29660%54.45%869466.67%85.21%6224.41%1129.45%771%727.25%
Research & Development36.6M52.2M28.17M34.86M43.45M48.67M39.5M40.26M43.17M41.62M39.99M42.33M40.21M33.44M36.44M38.59M32.86M15.29M31.43M46.45M
R&D % of Revenue1830200%869983.33%187813.33%435712.5%620671.43%442436.36%116176.47%309700%1439133.33%320146.15%159964%156766.67%61863.08%69.11%1214500%107.97%5941.59%541.99%1140.94%1767.35%
Other Operating Expenses-1000K-1000K-1000K1000K-119K1000K-730K-976K-1000K000000000-758K-223K
Operating Income-46.16M-61.31M-37.25M-47.14M-57.37M-201.15M-50.51M-51.53M-55.58M-59.83M-60.58M-65.87M-64.45M-15.99M-66.69M-37.03M-70.7M-48.34M-49.16M-62.71M
Operating Margin %-2307850%-1021866.67%-248353.33%-589250%-819528.57%-1828609.09%-148544.12%-396369.23%-1852500%-460230.77%-242308%-243959.26%-99156.92%-33.05%-2222933.33%-103.61%-12784.45%-1712.83%-1784.43%-2386.11%
Operating Income Growth %19.54%69.52%26.24%8.52%-3.22%-236.2%16.63%21.77%13.77%-274.08%9.16%-77.87%8.83%66.91%-35.65%40.94%-53.87%-22.3%--
EBITDA-43.83M-58.91M-34.69M-44.01M-53.93M-196.12M-45.83M-46.63M-50.55M-54.77M-55.47M-61.33M-59.42M-11.4M-62.52M-33.3M-66.72M-44.35M-45.07M-59.7M
EBITDA Margin %-2191250%-981916.67%-231246.67%-550062.5%-770371.43%-1782918.18%-134779.41%-358669.23%-1685033.33%-421330.77%-221892%-227148.15%-91423.08%-23.56%-2083866.7%-93.18%-12066%-1571.44%-1635.93%-2271.58%
EBITDA Growth %18.73%69.96%24.31%5.62%-6.68%-258.06%17.39%23.97%14.93%-380.38%11.27%-84.16%10.94%74.29%-38.71%44.21%-55.36%-16.48%--
D&A (Non-Cash Add-back)2.33M2.4M2.57M3.13M3.44M5.03M4.68M4.9M5.02M5.06M5.1M4.54M5.03M4.59M4.17M3.73M3.97M3.99M4.09M3.01M
EBIT-46.16M-61.31M-38.85M-45.7M-57.37M-62.67M-50.51M-51.53M-55.58M-52.93M-50.85M-63.89M-66.96M-8.4M-70.25M-36.32M-68.14M-83.71M-49.16M-62.71M
Net Interest Income2.19M2.68M3.27M3.28M3.86M4.92M5.96M6.36M6.82M7.08M6.61M5.26M4.5M3.45M2.25M952K397K323K270K218K
Interest Income2.19M2.68M3.27M3.28M3.86M4.92M5.96M6.36M6.82M7.08M6.61M5.26M4.5M3.45M2.25M952K397K323K270K218K
Interest Expense00000000000000000000
Other Income/Expense22M-79.41M-1.59M4.46M5.17M9.21M5.92M5.72M-5.09M6.9M9.72M1.98M-2.51M7.6M-3.57M709K2.55M-35.37M286K112K
Pretax Income-24.15M-140.72M-38.85M-42.68M-52.2M-191.94M-44.58M-45.81M-60.67M-52.93M-50.85M-63.89M-66.96M-8.4M-70.25M-36.32M-68.14M-83.71M-48.88M-62.59M
Pretax Margin %-1207650%-2345383.33%-258973.33%-533550%-745642.86%-1744863.64%-131126.47%-352376.92%-2022233.33%-407153.85%-203412%-236629.63%-103013.85%-17.35%-2341800%-101.63%-12322.6%-2966.19%-1774.05%-2381.85%
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-24.15M-140.72M-38.85M-42.68M-52.2M-191.94M-44.58M-45.81M-60.67M-52.93M-50.85M-63.89M-66.96M-8.4M-70.25M-36.32M-68.14M-83.71M-48.88M-62.59M
Net Margin %-1207650%-2345383.33%-258973.33%-533550%-745642.86%-1744863.64%-131126.47%-352376.92%-2022233.33%-407153.85%-203412%-236629.63%-103013.85%-17.35%-2341800%-101.63%-12322.6%-2966.19%-1774.05%-2381.85%
Net Income Growth %53.73%26.68%12.87%6.82%13.96%-262.62%12.33%28.3%9.4%-530.34%27.62%-75.89%1.74%89.97%-43.74%41.97%-23.8%-115.42%--
Net Income (Continuing)-24.15M-140.72M-38.85M-42.68M-52.2M-191.94M-44.58M-45.81M-60.67M-52.93M-50.85M-63.89M-66.96M-8.4M-70.25M-36.32M-68.14M-83.71M-48.88M-62.59M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-1.10-6.62-2.13-2.89-0.18-0.72-0.17-0.18-0.24-0.21-0.20-0.26-0.27-0.03-0.28-0.15-0.28-0.34-0.20-0.26
EPS Growth %-511.11%-819.44%-1152.94%-1510.93%24.56%-244.33%16.01%29.76%11.07%-522.32%28.46%-73.15%3.87%90.26%-38.81%43.79%-25.04%-115.5%--
EPS (Basic)-1.10-10.86-2.13-2.89-0.18-0.72-0.17-0.18-0.24-0.21-0.20-0.26-0.27-0.03-0.28-0.15-0.28-0.34-0.20-0.26
Diluted Shares Outstanding21.88M17.09M18.27M14.79M14.75M13.33M12.82M12.77M12.71M12.65M12.57M12.51M12.48M12.48M12.42M12.32M12.21M12.14M11.99M11.93M
Basic Shares Outstanding21.88M17.09M18.27M14.79M14.75M13.33M12.82M12.77M12.71M12.65M12.57M12.51M12.48M12.48M12.42M12.32M12.21M12.14M11.99M11.93M
Dividend Payout Ratio--------------------